ExodusPoint Capital Management’s ACM Research ACMR Stock Holding History

ExodusPoint Capital Management’s Portfolio ACMR Stock Details ACMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126K	Buy	3,200 +700	+28%	+$37.2K	﹤0.01%	1424
2025 Q4	$98.6K	Buy	+2,500	New	+$93.2K	﹤0.01%	1439

Other funds holding ACMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

PCP

Polunin Capital Partners London, United Kingdom $407M AUM 55.12% 1-Year Est. Return

ExodusPoint Capital Management's ACMR Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of ACM Research (ACMR) in Q4 2025, closing a stake of 47,411 shares — an estimated $1.77M sold.

ExodusPoint Capital Management first reported a position in ACMR in Q2 2019 and held it in 13 quarters. The position peaked at $3.38M in Q1 2021. 277 funds tracked by Wall St. Rank hold ACMR as of Q4 2025.

ExodusPoint Capital Management reported no remaining ACM Research position as of Q4 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 47,411 ACM Research shares in Q4 2025, an estimated $1.77M.
ExodusPoint Capital Management first reported a position in ACM Research in Q2 2019 and held it in 13 quarters.
ExodusPoint Capital Management's ACM Research position peaked at $3.38M in Q1 2021.
277 funds tracked by Wall St. Rank held ACM Research as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.